Skip to main content
Premium Trial:

Request an Annual Quote

Opko Health, Frost Group, SuperArray Bioscience, Carnegie Institution

Opko to Sell $20M in Stock to Frost Group
Opko Health said this week that it has sold $20 million in stock to the Frost Group, a private investment firm run by Opko Chairman and CEO Phillip Frost.
According to Opko, it will issue 10,869,565 shares of its common stock at $1.84 per share to the Frost Group, which represents a roughly 40 percent discount to the five-day average trading price of the stock on the American Stock Exchange.
Following completion of the deal, members of the Frost Group will hold about 62 percent of Opko’s outstanding shares.
The proceeds from the investment will be used to fund research and development efforts, including the ongoing phase III development of the RNAi-based wet age-related macular degeneration drug bevasiranib, and for general working capital.

SuperArray Licenses RNAi IP from Carnegie Institution
SuperArray Bioscience said last week that it has licensed RNAi-related intellectual property from the Carnegie Institution, which will allow the company to develop, manufacture, and distribute research tools based on the gene-silencing technology.
The worldwide license is non-exclusive, SuperArray noted. Additional details about the deal were not disclosed.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.